| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.56 | 0.011 | 0.56 | Calcium channel L-type activator | 0.271 0.184 DBMET00688 | ||
| 0.5 | 0.033 | 0.5 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.42 0.084 DBMET00688 | ||
| 0.461 | 0.034 | 0.461 | 5 Hydroxytryptamine release stimulant | 0.281 0.076 DBMET00688 | ||
| 0.432 | 0.015 | 0.432 | Calcium channel activator | 0.43 0.015 DBMET00688 | ||
| 0.442 | 0.044 | 0.451 | GABA C receptor rho-3 antagonist | 0.451 0.041 DBMET00688 | DBMET00688 | |
| 0.421 | 0.076 | 0.421 | Analgesic | |||
| 0.356 | 0.031 | 0.356 | Potassium channel blocker | |||
| 0.323 | 0.003 | 0.323 | Histamine agonist | |||
| 0.35 | 0.036 | 0.513 | Superoxide dismutase inhibitor | 0.513 0.012 DBMET00688 | DBMET00688 | |
| 0.309 | 0.004 | 0.309 | Nitric-oxide synthase inhibitor | 0.11 0.046 DBMET00688 | ||
| 0.296 | 0.004 | 0.296 | Toll-Like receptor 3 antagonist | |||
| 0.295 | 0.004 | 0.295 | Inducible nitric-oxide synthase inhibitor | 0.114 0.028 DBMET00688 | ||
| 0.292 | 0.005 | 0.292 | 5 Hydroxytryptamine 3E antagonist | 0.176 0.116 DBMET00688 | ||
| 0.316 | 0.03 | 0.316 | Ca(v)3.3 blocker | 0.221 0.15 DBMET00688 | ||
| 0.297 | 0.012 | 0.297 | Nitric-oxide synthase stimulant | 0.278 0.018 DBMET00688 | ||
| 0.307 | 0.025 | 0.307 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.323 | 0.046 | 0.358 | Insulysin inhibitor | 0.358 0.031 DBMET00688 | DBMET00688 | |
| 0.277 | 0.013 | 0.277 | Chelator | 0.224 0.02 DBMET00688 | ||
| 0.264 | 0.005 | 0.264 | Gastric antisecretory | 0.166 0.02 DBMET00688 | ||
| 0.306 | 0.05 | 0.306 | Antiamyloidogenic | 0.187 0.109 DBMET00688 | ||
| 0.315 | 0.065 | 0.315 | Spasmolytic | 0.172 0.143 DBMET00688 | ||
| 0.255 | 0.007 | 0.255 | CXC chemokine 4 receptor antagonist | 0.076 0.033 DBMET00688 | ||
| 0.257 | 0.013 | 0.257 | Antihistaminic | |||
| 0.316 | 0.075 | 0.316 | Vasodilator, coronary | 0.256 0.128 DBMET00688 | ||
| 0.252 | 0.013 | 0.252 | Histamine antagonist | |||
| 0.24 | 0.005 | 0.24 | Adenylate cyclase stimulant | 0.193 0.017 DBMET00688 | ||
| 0.245 | 0.013 | 0.245 | GABA C receptor rho-2 antagonist | 0.212 0.023 DBMET00688 | ||
| 0.227 | 0.004 | 0.227 | Histamine H2 receptor antagonist | |||
| 0.22 | 0.004 | 0.22 | Acetylcholine release stimulant | 0.15 0.016 DBMET00688 | ||
| 0.279 | 0.066 | 0.279 | Cardiotonic | |||
| 0.266 | 0.053 | 0.266 | Psychostimulant | 0.154 0.112 DBMET00688 | ||
| 0.224 | 0.012 | 0.224 | Histamine H1 receptor antagonist | 0.1 0.041 DBMET00688 | ||
| 0.257 | 0.046 | 0.257 | Peptidyltransferase inhibitor | 0.186 0.119 DBMET00688 | ||
| 0.267 | 0.06 | 0.267 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.265 | 0.063 | 0.319 | Gastrin inhibitor | 0.319 0.022 DBMET00688 | DBMET00688 | |
| 0.227 | 0.026 | 0.227 | Toll-Like receptor 9 antagonist | |||
| 0.25 | 0.05 | 0.299 | RNA-directed DNA polymerase inhibitor | 0.299 0.032 DBMET00688 | DBMET00688 | |
| 0.222 | 0.023 | 0.222 | Toll-Like receptor antagonist | |||
| 0.206 | 0.009 | 0.206 | Sphingomyelinase inhibitor | 0.101 0.059 DBMET00688 | ||
| 0.33 | 0.133 | 0.533 | 5 Hydroxytryptamine release inhibitor | 0.533 0.023 DBMET00688 | DBMET00688 | |
| 0.296 | 0.099 | 0.408 | Vasodilator, peripheral | 0.408 0.053 DBMET00688 | DBMET00688 | |
| 0.201 | 0.005 | 0.201 | Histamine N-methyltransferase inhibitor | 0.13 0.023 DBMET00688 | ||
| 0.234 | 0.039 | 0.234 | Growth factor agonist | |||
| 0.2 | 0.008 | 0.2 | CYP2A6 inhibitor | 0.104 0.034 DBMET00688 | ||
| 0.201 | 0.01 | 0.201 | Hematopoietic | 0.174 0.012 DBMET00688 | ||
| 0.21 | 0.02 | 0.216 | Antibacterial (Helicobacter pylori) | 0.216 0.018 DBMET00688 | DBMET00688 | |
| 0.201 | 0.012 | 0.742 | Porphobilinogen synthase inhibitor | 0.742 0.002 DBMET00688 | DBMET00688 | |
| 0.259 | 0.072 | 0.322 | 5 Hydroxytryptamine uptake stimulant | 0.322 0.035 DBMET00688 | DBMET00688 | |
| 0.339 | 0.154 | 0.493 | Caspase 9 stimulant | 0.493 0.062 DBMET00688 | DBMET00688 | |
| 0.267 | 0.086 | 0.267 | Hypoxia-inducible factor 1 alpha inhibitor | 0.247 0.103 DBMET00688 | ||
| 0.179 | 0.005 | 0.179 | Alpha 2 adrenoreceptor agonist | |||
| 0.17 | 0.001 | 0.17 | Histamine H1 receptor agonist | 0.06 0.009 DBMET00688 | ||
| 0.169 | 0.002 | 0.169 | Histamine H2 receptor agonist | 0.063 0.013 DBMET00688 | ||
| 0.187 | 0.023 | 0.672 | GABA C receptor agonist | 0.672 0.002 DBMET00688 | DBMET00688 | |
| 0.174 | 0.01 | 0.174 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.183 | 0.02 | 0.183 | 5 Hydroxytryptamine 3A agonist | 0.128 0.049 DBMET00688 | ||
| 0.164 | 0.003 | 0.164 | Diamine oxidase inhibitor | 0.04 0.023 DBMET00688 | ||
| 0.172 | 0.012 | 0.172 | Alpha adrenoreceptor agonist | |||
| 0.184 | 0.026 | 0.184 | Nav1.6 sodium channel blocker | 0.14 0.067 DBMET00688 | ||
| 0.17 | 0.012 | 0.17 | Acetylcholine nicotinic agonist | |||
| 0.171 | 0.014 | 0.265 | GABA C receptor rho-1 antagonist | 0.265 0.004 DBMET00688 | DBMET00688 | |
| 0.211 | 0.056 | 0.53 | Peroxidase inhibitor | 0.53 0.007 DBMET00688 | DBMET00688 | |
| 0.281 | 0.127 | 0.281 | Calpain 2 inhibitor | |||
| 0.22 | 0.068 | 0.22 | Amyloid beta aggregation inhibitor | |||
| 0.156 | 0.005 | 0.156 | Histamine H3 receptor agonist | |||
| 0.152 | 0.008 | 0.152 | Nicotinic alpha4beta2 receptor antagonist | 0.108 0.025 DBMET00688 | ||
| 0.28 | 0.135 | 0.505 | Histamine release inhibitor | 0.505 0.027 DBMET00688 | DBMET00688 | |
| 0.187 | 0.042 | 0.187 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.148 | 0.004 | 0.148 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.229 | 0.086 | 0.229 | Calpain inhibitor | 0.178 0.138 DBMET00688 | ||
| 0.18 | 0.038 | 0.18 | Cholinergic antagonist | |||
| 0.233 | 0.091 | 0.279 | DNA damaging | 0.279 0.066 DBMET00688 | DBMET00688 | |
| 0.162 | 0.021 | 0.162 | Nav1.5 sodium channel blocker | 0.103 0.08 DBMET00688 | ||
| 0.154 | 0.014 | 0.154 | Adrenaline agonist | 0.078 0.06 DBMET00688 | ||
| 0.15 | 0.009 | 0.15 | Adrenaline uptake inhibitor | |||
| 0.151 | 0.012 | 0.294 | Phenylalanine 4-hydroxylase inhibitor | 0.294 0.004 DBMET00688 | DBMET00688 | |
| 0.186 | 0.046 | 0.186 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.176 | 0.038 | 0.176 | Acetylcholine antagonist | |||
| 0.155 | 0.019 | 0.155 | Acetylcholine nicotinic antagonist | 0.083 0.051 DBMET00688 | ||
| 0.14 | 0.005 | 0.14 | 5 Hydroxytryptamine 3 agonist | 0.066 0.039 DBMET00688 | ||
| 0.144 | 0.012 | 0.144 | CXC chemokine receptor antagonist | 0.078 0.04 DBMET00688 | ||
| 0.169 | 0.037 | 0.169 | Nav1.3 sodium channel blocker | |||
| 0.152 | 0.022 | 0.152 | Transcription factor STAT6 inhibitor | 0.115 0.068 DBMET00688 | ||
| 0.215 | 0.085 | 0.215 | MAP kinase kinase 3 inhibitor | 0.188 0.163 DBMET00688 | ||
| 0.138 | 0.009 | 0.138 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.201 | 0.072 | 0.27 | Insulin sensitizer | 0.27 0.025 DBMET00688 | DBMET00688 | |
| 0.155 | 0.027 | 0.264 | GABA C receptor antagonist | 0.264 0.005 DBMET00688 | DBMET00688 | |
| 0.141 | 0.016 | 0.141 | Glutamate (mGluR7) agonist | 0.112 0.04 DBMET00688 | ||
| 0.134 | 0.01 | 0.134 | Potassium channel Kv1.5 blocker | |||
| 0.138 | 0.014 | 0.138 | Neuronal nicotinic receptor antagonist | 0.073 0.042 DBMET00688 | ||
| 0.126 | 0.005 | 0.126 | 5 Hydroxytryptamine 1B agonist | |||
| 0.131 | 0.01 | 0.131 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.172 | 0.055 | 0.172 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.192 | 0.078 | 0.192 | I kappa B kinase epsilon inhibitor | |||
| 0.219 | 0.105 | 0.321 | Tyrosine 3 hydroxylase inhibitor | 0.321 0.024 DBMET00688 | DBMET00688 | |
| 0.125 | 0.014 | 0.125 | Carbonic anhydrase stimulant | 0.079 0.026 DBMET00688 | ||
| 0.115 | 0.006 | 0.115 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.12 | 0.012 | 0.12 | Toll-Like receptor 7 antagonist | |||
| 0.111 | 0.004 | 0.111 | Dopamine beta hydroxylase inhibitor | 0.097 0.004 DBMET00688 | ||
| 0.167 | 0.06 | 0.167 | Acetylcholine M1 receptor antagonist | 0.127 0.099 DBMET00688 | ||
| 0.192 | 0.085 | 0.248 | Neurotrophic factor enhancer | 0.248 0.04 DBMET00688 | DBMET00688 | |
| 0.114 | 0.007 | 0.114 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.099 0.014 DBMET00688 | ||
| 0.171 | 0.069 | 0.171 | ATPase inhibitor | 0.154 0.095 DBMET00688 | ||
| 0.111 | 0.011 | 0.111 | Potassium channel (ATP-sensitive) blocker | |||
| 0.137 | 0.04 | 0.137 | Protein kinase C gamma inhibitor | |||
| 0.097 | 0.004 | 0.097 | Methionyl aminopeptidase 1 inhibitor | 0.075 0.004 DBMET00688 | ||
| 0.141 | 0.049 | 0.141 | Acetylcholine muscarinic antagonist | |||
| 0.179 | 0.088 | 0.179 | Focal adhesion kinase 2 inhibitor | |||
| 0.264 | 0.173 | 0.264 | MAP kinase kinase 6 inhibitor | |||
| 0.111 | 0.021 | 0.111 | Acetylcholine M4 receptor antagonist | |||
| 0.089 | 0.003 | 0.089 | Histamine H4 receptor agonist | |||
| 0.135 | 0.048 | 0.135 | DNA repair enzyme inhibitor | 0.112 0.089 DBMET00688 | ||
| 0.09 | 0.005 | 0.09 | 5 Hydroxytryptamine 1D agonist | |||
| 0.097 | 0.013 | 0.097 | Histamine H3 receptor antagonist | |||
| 0.098 | 0.014 | 0.098 | Protein kinase C beta inhibitor | 0.085 0.024 DBMET00688 | ||
| 0.144 | 0.061 | 0.163 | Heat shock protein 70 antagonist | 0.163 0.025 DBMET00688 | DBMET00688 | |
| 0.142 | 0.06 | 0.166 | NADPH oxidase inhibitor | 0.166 0.046 DBMET00688 | DBMET00688 | |
| 0.11 | 0.028 | 0.11 | Somatostatin 1 agonist | 0.072 0.062 DBMET00688 | ||
| 0.129 | 0.049 | 0.257 | GABA receptor agonist | 0.257 0.01 DBMET00688 | DBMET00688 | |
| 0.125 | 0.046 | 0.125 | Alpha 2c adrenoreceptor antagonist | |||
| 0.084 | 0.005 | 0.084 | Immunoglobulin Fc receptor antagonist | 0.07 0.011 DBMET00688 | ||
| 0.107 | 0.028 | 0.107 | Myeloperoxidase inhibitor | |||
| 0.093 | 0.015 | 0.093 | Nicotinic neuronal receptor agonist | |||
| 0.086 | 0.01 | 0.086 | Potassium channel (Inward rectifier) blocker | |||
| 0.129 | 0.053 | 0.129 | DNA intercalator | |||
| 0.089 | 0.013 | 0.089 | Histone deacetylase SIRT3 inhibitor | |||
| 0.083 | 0.008 | 0.083 | Histamine H4 receptor antagonist | |||
| 0.132 | 0.058 | 0.132 | 5 Hydroxytryptamine antagonist | |||
| 0.113 | 0.039 | 0.113 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.092 | 0.02 | 0.092 | Phospholipase D inhibitor | 0.077 0.039 DBMET00688 | ||
| 0.084 | 0.011 | 0.084 | Epithelial sodium channel blocker | |||
| 0.08 | 0.008 | 0.08 | Adenylate cyclase 1 inhibitor | 0.043 0.037 DBMET00688 | ||
| 0.111 | 0.04 | 0.111 | Acetylcholine agonist | |||
| 0.097 | 0.027 | 0.097 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.125 | 0.055 | 0.204 | Interleukin 8 antagonist | 0.204 0.012 DBMET00688 | DBMET00688 | |
| 0.136 | 0.067 | 0.136 | Sodium channel (voltage-gated) blocker | |||
| 0.116 | 0.047 | 0.116 | Bronchodilator | |||
| 0.088 | 0.019 | 0.088 | Potassium channel (Tandem pore domain) blocker | 0.07 0.063 DBMET00688 | ||
| 0.074 | 0.006 | 0.078 | Geranyltranstransferase inhibitor | 0.078 0.005 DBMET00688 | DBMET00688 | |
| 0.105 | 0.039 | 0.113 | Ornithine decarboxylase inhibitor | 0.113 0.031 DBMET00688 | DBMET00688 | |
| 0.165 | 0.1 | 0.398 | Non-steroidal antiinflammatory agent | 0.398 0.014 DBMET00688 | DBMET00688 | |
| 0.101 | 0.036 | 0.154 | GABA A receptor agonist | 0.154 0.015 DBMET00688 | DBMET00688 | |
| 0.091 | 0.026 | 0.091 | Transforming growth factor antagonist | |||
| 0.164 | 0.1 | 0.337 | Anesthetic general | 0.337 0.026 DBMET00688 | DBMET00688 | |
| 0.076 | 0.012 | 0.076 | Stearoyl-CoA desaturase inhibitor | 0.072 0.013 DBMET00688 | ||
| 0.076 | 0.012 | 0.076 | Histone deacetylase 7 inhibitor | |||
| 0.071 | 0.007 | 0.071 | Alpha 1d adrenoreceptor agonist | |||
| 0.153 | 0.09 | 0.175 | Antipruritic | 0.175 0.069 DBMET00688 | DBMET00688 | |
| 0.135 | 0.073 | 0.135 | Aurora-C kinase inhibitor | |||
| 0.139 | 0.077 | 0.141 | Pregnane X receptor agonist | 0.141 0.072 DBMET00688 | DBMET00688 | |
| 0.075 | 0.014 | 0.075 | Beta 2 adrenoreceptor antagonist | 0.049 0.038 DBMET00688 | ||
| 0.065 | 0.004 | 0.065 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.079 | 0.018 | 0.079 | Beta 1 adrenoreceptor antagonist | |||
| 0.106 | 0.045 | 0.16 | Interleukin 12 antagonist | 0.16 0.01 DBMET00688 | DBMET00688 | |
| 0.11 | 0.049 | 0.23 | Creatine kinase inhibitor | 0.23 0.007 DBMET00688 | DBMET00688 | |
| 0.075 | 0.016 | 0.399 | Aconitate hydratase inhibitor | 0.399 0.002 DBMET00688 | DBMET00688 | |
| 0.084 | 0.024 | 0.084 | Beta adrenoreceptor antagonist | |||
| 0.123 | 0.064 | 0.149 | Beta amyloid protein antagonist | 0.149 0.041 DBMET00688 | DBMET00688 | |
| 0.078 | 0.019 | 0.078 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.091 | 0.035 | 0.091 | Transforming growth factor beta 3 antagonist | 0.079 0.069 DBMET00688 | ||
| 0.129 | 0.074 | 0.129 | Nav1.2 sodium channel blocker | |||
| 0.065 | 0.01 | 0.065 | Histone deacetylase 9 inhibitor | |||
| 0.07 | 0.016 | 0.07 | Phosphodiesterase X inhibitor | |||
| 0.07 | 0.016 | 0.07 | Phosphodiesterase 10A inhibitor | |||
| 0.069 | 0.015 | 0.157 | Glutamate (mGluR group III) agonist | 0.157 0.005 DBMET00688 | DBMET00688 | |
| 0.079 | 0.025 | 0.079 | Acetylcholine M5 receptor antagonist | |||
| 0.115 | 0.062 | 0.115 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.09 | 0.038 | 0.09 | Rho-associated kinase I inhibitor | |||
| 0.077 | 0.025 | 0.077 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.114 | 0.063 | 0.114 | Alpha 2b adrenoreceptor antagonist | |||
| 0.103 | 0.052 | 0.136 | Lanosterol 14 alpha demethylase inhibitor | 0.136 0.018 DBMET00688 | DBMET00688 | |
| 0.09 | 0.04 | 0.09 | Estrogen-related receptor beta agonist | 0.086 0.05 DBMET00688 | ||
| 0.204 | 0.154 | 0.204 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.15 | 0.101 | 0.178 | Neurotensin receptor agonist | 0.178 0.052 DBMET00688 | DBMET00688 | |
| 0.207 | 0.158 | 0.568 | Cholesterol antagonist | 0.568 0.023 DBMET00688 | DBMET00688 | |
| 0.189 | 0.14 | 0.189 | Neuropeptide Y2 antagonist | 0.178 0.165 DBMET00688 | ||
| 0.075 | 0.026 | 0.129 | Glutamate (mGluR1) antagonist | 0.129 0.009 DBMET00688 | DBMET00688 | |
| 0.053 | 0.004 | 0.053 | Myristoyl transferase inhibitor | |||
| 0.108 | 0.059 | 0.108 | MAO A inhibitor | |||
| 0.071 | 0.023 | 0.071 | Toll-Like receptor 8 antagonist | |||
| 0.082 | 0.034 | 0.082 | Secretase beta inhibitor | 0.065 0.06 DBMET00688 | ||
| 0.067 | 0.02 | 0.067 | H+/K+-transporting ATPase inhibitor | |||
| 0.096 | 0.049 | 0.096 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.081 | 0.036 | 0.081 | Amidase inhibitor | 0.063 0.06 DBMET00688 | ||
| 0.059 | 0.014 | 0.059 | Benzodiazepine antagonist | 0.051 0.024 DBMET00688 | ||
| 0.134 | 0.089 | 0.134 | Thiol protease inhibitor | 0.129 0.098 DBMET00688 | ||
| 0.127 | 0.082 | 0.127 | Cytokine production inhibitor | |||
| 0.206 | 0.162 | 0.206 | Angiogenesis inhibitor | |||
| 0.066 | 0.022 | 0.066 | Transforming growth factor beta 1 antagonist | |||
| 0.153 | 0.109 | 0.153 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.087 | 0.043 | 0.087 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.114 | 0.071 | 0.114 | Calcium channel N-type blocker | |||
| 0.059 | 0.015 | 0.059 | Glutamate (mGluR1a) antagonist | |||
| 0.067 | 0.023 | 0.067 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.073 | 0.03 | 0.073 | Acetylcholine M3 receptor antagonist | |||
| 0.092 | 0.051 | 0.092 | Protein kinase A inhibitor | |||
| 0.062 | 0.021 | 0.093 | Glutamate (mGluR group I) agonist | 0.093 0.009 DBMET00688 | DBMET00688 | |
| 0.072 | 0.031 | 0.072 | Beta 3 adrenoreceptor antagonist | |||
| 0.071 | 0.03 | 0.071 | Bombesin 1 receptor agonist | |||
| 0.069 | 0.028 | 0.069 | Alpha 1 adrenoreceptor agonist | |||
| 0.067 | 0.026 | 0.067 | Beta 2 adrenoreceptor agonist | |||
| 0.159 | 0.122 | 0.159 | HERG channel blocker | |||
| 0.042 | 0.005 | 0.042 | Apolipoprotein B inhibitor | |||
| 0.145 | 0.108 | 0.145 | Tumour necrosis factor antagonist | 0.142 0.111 DBMET00688 | ||
| 0.12 | 0.084 | 0.12 | Sodium channel blocker | |||
| 0.132 | 0.096 | 0.132 | Neuropeptide Y1 antagonist | |||
| 0.061 | 0.025 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.111 | 0.075 | 0.111 | TRKA antagonist | |||
| 0.052 | 0.016 | 0.052 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.072 | 0.037 | 0.072 | Orexin receptor antagonist | |||
| 0.065 | 0.031 | 0.084 | Botulinum neurotoxin type A inhibitor | 0.084 0.015 DBMET00688 | DBMET00688 | |
| 0.05 | 0.016 | 0.05 | Vascular adhesion protein 1 inhibitor | |||
| 0.066 | 0.032 | 0.066 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.038 | 0.004 | 0.038 | Nicotinic alpha4 receptor agonist | |||
| 0.04 | 0.007 | 0.04 | Purinergic P2Y15 antagonist | 0.036 0.01 DBMET00688 | ||
| 0.062 | 0.029 | 0.062 | Nicotinic alpha7 receptor agonist | |||
| 0.054 | 0.021 | 0.054 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.039 | 0.007 | 0.039 | MAP3K8 inhibitor | |||
| 0.05 | 0.018 | 0.05 | Beta adrenoreceptor agonist | 0.044 0.036 DBMET00688 | ||
| 0.062 | 0.032 | 0.062 | 5 Hydroxytryptamine 1 agonist | |||
| 0.195 | 0.165 | 0.195 | Nootropic | |||
| 0.034 | 0.004 | 0.034 | Alpha 2c adrenoreceptor agonist | |||
| 0.076 | 0.046 | 0.147 | Aminopeptidase I inhibitor | 0.147 0.013 DBMET00688 | DBMET00688 | |
| 0.041 | 0.011 | 0.041 | Transforming growth factor beta 2 antagonist | |||
| 0.059 | 0.03 | 0.112 | Thromboxane synthase inhibitor | 0.112 0.005 DBMET00688 | DBMET00688 | |
| 0.087 | 0.058 | 0.087 | Insulin growth factor antagonist | |||
| 0.068 | 0.039 | 0.068 | 5 Hydroxytryptamine 2A agonist | |||
| 0.054 | 0.026 | 0.054 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.068 | 0.04 | 0.068 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.061 | 0.033 | 0.155 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.155 0.008 DBMET00688 | DBMET00688 | |
| 0.084 | 0.057 | 0.084 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.106 | 0.08 | 0.117 | Microtubule formation inhibitor | 0.117 0.064 DBMET00688 | DBMET00688 | |
| 0.083 | 0.057 | 0.083 | Insulin like growth factor 1 antagonist | |||
| 0.083 | 0.057 | 0.083 | MAP-kinase-activated kinase inhibitor | |||
| 0.065 | 0.04 | 0.065 | Acetylcholine M2 receptor antagonist | |||
| 0.13 | 0.106 | 0.13 | MAP kinase 3 inhibitor | 0.125 0.121 DBMET00688 | ||
| 0.04 | 0.015 | 0.04 | Melatonin 1 agonist | |||
| 0.036 | 0.012 | 0.036 | CDK4/cyclin D3 inhibitor | |||
| 0.072 | 0.048 | 0.404 | Histidine decarboxylase inhibitor | 0.404 0.004 DBMET00688 | DBMET00688 | |
| 0.092 | 0.068 | 0.127 | Interleukin 1 beta converting enzyme inhibitor | 0.127 0.03 DBMET00688 | DBMET00688 | |
| 0.044 | 0.02 | 0.044 | Factor XIIIa inhibitor | |||
| 0.104 | 0.081 | 0.107 | Adenylate cyclase inhibitor | 0.107 0.078 DBMET00688 | DBMET00688 | |
| 0.085 | 0.063 | 0.121 | Granulocyte macrophage colony stimulating factor agonist | 0.121 0.015 DBMET00688 | DBMET00688 | |
| 0.05 | 0.028 | 0.055 | Cytokine production stimulant | 0.055 0.019 DBMET00688 | DBMET00688 | |
| 0.074 | 0.052 | 0.074 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.029 | 0.007 | 0.029 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.03 | 0.008 | 0.119 | Integrin alphaVbeta3 antagonist | 0.119 0.004 DBMET00688 | DBMET00688 | |
| 0.092 | 0.071 | 0.099 | Phosphodiesterase 6D inhibitor | 0.099 0.054 DBMET00688 | DBMET00688 | |
| 0.06 | 0.039 | 0.087 | Sphingosine 1-phosphate receptor 3 antagonist | 0.087 0.013 DBMET00688 | DBMET00688 | |
| 0.09 | 0.069 | 0.09 | MAP kinase kinase 1 inhibitor | |||
| 0.026 | 0.005 | 0.026 | Alpha 2b adrenoreceptor agonist | 0.018 0.014 DBMET00688 | ||
| 0.073 | 0.052 | 0.161 | Glutamate dehydrogenase inhibitor | 0.161 0.014 DBMET00688 | DBMET00688 | |
| 0.033 | 0.013 | 0.033 | 5 Hydroxytryptamine 6 agonist | |||
| 0.044 | 0.024 | 0.121 | Integrin alpha5beta1 antagonist | 0.121 0.005 DBMET00688 | DBMET00688 | |
| 0.101 | 0.082 | 0.101 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.05 | 0.031 | 0.179 | AMPA receptor antagonist | 0.179 0.005 DBMET00688 | DBMET00688 | |
| 0.053 | 0.035 | 0.053 | 5 Hydroxytryptamine 2 agonist | |||
| 0.119 | 0.101 | 0.119 | Cytidine deaminase inhibitor | 0.118 0.102 DBMET00688 | ||
| 0.044 | 0.027 | 0.05 | Nerve growth factor antagonist | 0.05 0.018 DBMET00688 | DBMET00688 | |
| 0.036 | 0.019 | 0.036 | Melatonin agonist | |||
| 0.022 | 0.005 | 0.099 | Egl nine homolog 1 inhibitor | 0.099 0.002 DBMET00688 | DBMET00688 | |
| 0.036 | 0.019 | 0.036 | Melatonin receptor 1A agonist | |||
| 0.032 | 0.015 | 0.032 | Thrombin receptor antagonist | |||
| 0.024 | 0.008 | 0.024 | Apolipoprotein B-100 inhibitor | |||
| 0.106 | 0.089 | 0.243 | Glutamate receptor antagonist | 0.243 0.017 DBMET00688 | DBMET00688 | |
| 0.068 | 0.051 | 0.09 | Glutamate (mGluR group I) antagonist | 0.09 0.031 DBMET00688 | DBMET00688 | |
| 0.033 | 0.017 | 0.033 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.061 | 0.045 | 0.118 | NMDA receptor agonist | 0.118 0.014 DBMET00688 | DBMET00688 | |
| 0.042 | 0.026 | 0.042 | Plasmepsin II inhibitor | |||
| 0.114 | 0.099 | 0.114 | Histone deacetylase SIRT1 inhibitor | |||
| 0.037 | 0.022 | 0.037 | ATM kinase inhibitor | |||
| 0.071 | 0.056 | 0.071 | Protein kinase B beta inhibitor | |||
| 0.067 | 0.052 | 0.067 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.05 | 0.035 | 0.05 | Alpha 1b adrenoreceptor agonist | |||
| 0.03 | 0.015 | 0.144 | Protocollagen prolyl hydroxylase inhibitor | 0.144 0.004 DBMET00688 | DBMET00688 | |
| 0.088 | 0.074 | 0.187 | Aminopeptidase B inhibitor | 0.187 0.025 DBMET00688 | DBMET00688 | |
| 0.042 | 0.028 | 0.062 | Angiotensin AT1 receptor antagonist | 0.062 0.005 DBMET00688 | DBMET00688 | |
| 0.031 | 0.017 | 0.031 | Melatonin antagonist | |||
| 0.043 | 0.03 | 0.043 | Carbonic anhydrase IV inhibitor | |||
| 0.054 | 0.04 | 0.054 | Glucosylceramidase inhibitor | |||
| 0.038 | 0.025 | 0.038 | Carbonic anhydrase I stimulant | |||
| 0.06 | 0.047 | 0.06 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.075 | 0.062 | 0.075 | MAP kinase kinase 7 inhibitor | |||
| 0.064 | 0.052 | 0.064 | 5 Hydroxytryptamine agonist | |||
| 0.046 | 0.034 | 0.046 | Benzodiazepine inverse agonist | |||
| 0.044 | 0.032 | 0.044 | Oleamide hydrolase inhibitor | |||
| 0.034 | 0.022 | 0.034 | Melatonin 2 agonist | |||
| 0.045 | 0.033 | 0.065 | Glutamate (mGluR5) agonist | 0.065 0.015 DBMET00688 | DBMET00688 | |
| 0.055 | 0.044 | 0.055 | Protein kinase C theta inhibitor | |||
| 0.063 | 0.053 | 0.063 | Nav1.7 sodium channel blocker | |||
| 0.071 | 0.061 | 0.071 | Vanilloid 4 agonist | |||
| 0.084 | 0.074 | 0.084 | Polo-like kinase-1 inhibitor | |||
| 0.052 | 0.042 | 0.052 | Myc inhibitor | |||
| 0.069 | 0.059 | 0.069 | Orexin receptor 1 antagonist | |||
| 0.021 | 0.011 | 0.104 | Integrin alphaVbeta1 antagonist | 0.104 0.004 DBMET00688 | DBMET00688 | |
| 0.154 | 0.145 | 0.282 | Cyclic AMP phosphodiesterase inhibitor | 0.282 0.049 DBMET00688 | DBMET00688 | |
| 0.034 | 0.024 | 0.057 | Angiotensin II receptor antagonist | 0.057 0.005 DBMET00688 | DBMET00688 | |
| 0.084 | 0.075 | 0.108 | Prolactin inhibitor | 0.108 0.048 DBMET00688 | DBMET00688 | |
| 0.113 | 0.105 | 0.114 | Vanilloid 1 agonist | 0.114 0.102 DBMET00688 | DBMET00688 | |
| 0.09 | 0.081 | 0.09 | Falcipain 3 inhibitor | |||
| 0.019 | 0.01 | 0.019 | Alpha 2a adrenoreceptor agonist | |||
| 0.104 | 0.096 | 0.358 | Alpha-N-acetylglucosaminidase inhibitor | 0.358 0.011 DBMET00688 | DBMET00688 | |
| 0.129 | 0.121 | 0.142 | CF transmembrane conductance regulator agonist | 0.142 0.092 DBMET00688 | DBMET00688 | |
| 0.06 | 0.053 | 0.06 | Histone deacetylase inhibitor | |||
| 0.021 | 0.014 | 0.154 | Integrin beta5 antagonist | 0.154 0.004 DBMET00688 | DBMET00688 | |
| 0.039 | 0.032 | 0.039 | Oxytocin agonist | |||
| 0.028 | 0.022 | 0.147 | AMPA 3 receptor antagonist | 0.147 0.004 DBMET00688 | DBMET00688 | |
| 0.148 | 0.142 | 0.148 | Histone acetyltransferase inhibitor | |||
| 0.048 | 0.042 | 0.076 | Ribonucleoside-diphosphate reductase inhibitor | 0.076 0.026 DBMET00688 | DBMET00688 | |
| 0.016 | 0.01 | 0.016 | Adenosine A2a receptor agonist | |||
| 0.029 | 0.023 | 0.029 | Peptide deformylase inhibitor | |||
| 0.015 | 0.009 | 0.027 | Integrin beta6 antagonist | 0.027 0.003 DBMET00688 | DBMET00688 | |
| 0.068 | 0.062 | 0.068 | Adenosine A3 receptor antagonist | |||
| 0.019 | 0.013 | 0.019 | Melatonin 1 antagonist | |||
| 0.048 | 0.043 | 0.077 | Ribonucleotide reductase inhibitor | 0.077 0.028 DBMET00688 | DBMET00688 | |
| 0.022 | 0.018 | 0.022 | Dopamine autoreceptor agonist | |||
| 0.187 | 0.182 | 0.3 | Transcription factor NF kappa B inhibitor | 0.3 0.094 DBMET00688 | DBMET00688 | |
| 0.063 | 0.058 | 0.114 | Glutamate (mGluR7) antagonist | 0.114 0.005 DBMET00688 | DBMET00688 | |
| 0.015 | 0.011 | 0.015 | CXC chemokine 4 receptor agonist | 0.014 0.011 DBMET00688 | ||
| 0.041 | 0.037 | 0.041 | Protease activated receptor 1 antagonist | |||
| 0.016 | 0.012 | 0.016 | Adenosine A2 receptor agonist | |||
| 0.02 | 0.015 | 0.02 | Toll-Like receptor 8 agonist | |||
| 0.01 | 0.006 | 0.01 | Baculoviral IAP repeat-containing protein 2 inhibitor | |||
| 0.078 | 0.075 | 0.078 | mTOR complex 2 inhibitor | |||
| 0.088 | 0.085 | 0.327 | Ferrochelatase inhibitor | 0.327 0.005 DBMET00688 | DBMET00688 | |
| 0.06 | 0.058 | 0.06 | Check point kinase 1 inhibitor | |||
| 0.042 | 0.04 | 0.042 | Potassium channel Kv1.3 blocker | |||
| 0.096 | 0.094 | 0.096 | Activin receptor-like kinase 4 inhibitor | |||
| 0.026 | 0.024 | 0.026 | Glucosylceramidase stimulant | |||
| 0.024 | 0.023 | 0.024 | Acid ceramidase inhibitor | |||
| 0.055 | 0.054 | 0.06 | Ryanodine receptor antagonist | 0.06 0.038 DBMET00688 | DBMET00688 | |
| 0.075 | 0.074 | 0.083 | Caspase 7 inhibitor | 0.083 0.054 DBMET00688 | DBMET00688 | |
| 0.017 | 0.017 | 0.02 | Complement factor D inhibitor | 0.02 0.009 DBMET00688 | DBMET00688 | |
| 0.012 | 0.012 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.009 DBMET00688 | DBMET00688 | |
| 0.034 | 0.034 | 0.057 | DNA gyrase subunit B inhibitor | 0.057 0.01 DBMET00688 | DBMET00688 | |
| 0.005 | 0.007 | 0.017 | Integrin alpha5beta6 antagonist | 0.017 0.002 DBMET00688 | DBMET00688 | |
| 0.057 | 0.058 | 0.144 | Sphingosine 1-phosphate receptor 4 agonist | 0.144 0.01 DBMET00688 | DBMET00688 | |
| 0.047 | 0.05 | 0.5 | Alcohol oxidase inhibitor | 0.5 0.004 DBMET00688 | DBMET00688 | |
| 0.079 | 0.082 | 0.35 | Alcohol dehydrogenase inhibitor | 0.35 0.004 DBMET00688 | DBMET00688 | |
| 0.029 | 0.033 | 0.038 | Phosphoglycerate kinase inhibitor | 0.038 0.021 DBMET00688 | DBMET00688 | |
| 0.038 | 0.043 | 0.059 | AICAR transformylase inhibitor | 0.059 0.015 DBMET00688 | DBMET00688 | |
| 0.12 | 0.126 | 0.239 | Arachidonic acid antagonist | 0.239 0.008 DBMET00688 | DBMET00688 | |
| 0.011 | 0.016 | 0.023 | Integrin alphaVbeta6 antagonist | 0.023 0.005 DBMET00688 | DBMET00688 | |
| 0.082 | 0.088 | 0.119 | Carbonic anhydrase III inhibitor | 0.119 0.045 DBMET00688 | DBMET00688 | |
| 0.016 | 0.022 | 0.156 | Vitronectin receptor antagonist | 0.156 0.004 DBMET00688 | DBMET00688 | |
| 0.038 | 0.044 | 0.056 | Antimetabolite | 0.056 0.028 DBMET00688 | DBMET00688 | |
| 0.005 | 0.013 | 0.026 | Integrin alphaVbeta5 antagonist | 0.026 0.004 DBMET00688 | DBMET00688 | |
| 0.043 | 0.052 | 0.084 | Acyl-CoA dehydrogenase inhibitor | 0.084 0.021 DBMET00688 | DBMET00688 | |
| 0.076 | 0.084 | 0.082 | Potassium channel activator | 0.082 0.072 DBMET00688 | DBMET00688 | |
| 0.087 | 0.095 | 0.231 | Adenylate kinase inhibitor | 0.231 0.011 DBMET00688 | DBMET00688 | |
| 0.026 | 0.035 | 0.028 | Thiazolidinedione | 0.028 0.027 DBMET00688 | DBMET00688 | |
| 0.008 | 0.019 | 0.023 | Egl nine homolog 3 inhibitor | 0.023 0.004 DBMET00688 | DBMET00688 | |
| 0.029 | 0.04 | 0.035 | Benzodiazepine receptor peripheral-type antagonist | 0.035 0.022 DBMET00688 | DBMET00688 | |
| 0.02 | 0.032 | 0.058 | Glutamate (mGluR1) agonist | 0.058 0.004 DBMET00688 | DBMET00688 | |
| 0.016 | 0.03 | 0.048 | Prostaglandin H2 antagonist | 0.048 0.004 DBMET00688 | DBMET00688 | |
| 0.097 | 0.113 | 0.126 | Cathepsin H inhibitor | 0.126 0.067 DBMET00688 | DBMET00688 | |
| 0.013 | 0.029 | 0.028 | Hexokinase stimulant | 0.028 0.009 DBMET00688 | DBMET00688 | |
| 0.01 | 0.026 | 0.02 | Ileal bile acid transport inhibitor | 0.02 0.009 DBMET00688 | DBMET00688 | |
| 0.06 | 0.077 | 0.166 | Glutamate receptor agonist | 0.166 0.015 DBMET00688 | DBMET00688 | |
| 0.111 | 0.128 | 0.277 | Insulin secretagoues | 0.277 0.015 DBMET00688 | DBMET00688 | |
| 0.027 | 0.045 | 0.104 | Glutamate (mGluR4) agonist | 0.104 0.004 DBMET00688 | DBMET00688 | |
| 0.04 | 0.058 | 0.048 | Topoisomerase II beta inhibitor | 0.048 0.036 DBMET00688 | DBMET00688 | |
| 0.054 | 0.073 | 0.089 | Interferon inducer | 0.089 0.017 DBMET00688 | DBMET00688 | |
| 0.039 | 0.059 | 0.086 | Lysophosphatidic acid 3 receptor antagonist | 0.086 0.007 DBMET00688 | DBMET00688 | |
| 0.034 | 0.054 | 0.053 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.053 0.012 DBMET00688 | DBMET00688 | |
| 0.029 | 0.05 | 0.051 | Tryptophan 5 hydroxylase inhibitor | 0.051 0.005 DBMET00688 | DBMET00688 | |
| 0.078 | 0.099 | 0.091 | Glutamate release inhibitor | 0.091 0.059 DBMET00688 | DBMET00688 | |
| 0.037 | 0.06 | 0.061 | Carbonic anhydrase VB inhibitor | 0.061 0.034 DBMET00688 | DBMET00688 | |
| 0.13 | 0.155 | 0.234 | Anticonvulsant | 0.234 0.063 DBMET00688 | DBMET00688 | |
| 0.016 | 0.044 | 0.034 | Lysine carboxypeptidase inhibitor | 0.034 0.013 DBMET00688 | DBMET00688 | |
| 0.077 | 0.105 | 0.163 | Electrolyte absorption antagonist | 0.163 0.015 DBMET00688 | DBMET00688 | |
| 0.031 | 0.059 | 0.053 | Vanilloid 3 antagonist | 0.053 0.007 DBMET00688 | DBMET00688 | |
| 0.047 | 0.076 | 0.072 | Pregnane X receptor antagonist | 0.072 0.012 DBMET00688 | DBMET00688 | |
| 0.062 | 0.091 | 0.105 | Interferon agonist | 0.105 0.025 DBMET00688 | DBMET00688 | |
| 0.054 | 0.083 | 0.062 | Transcription factor RelA inhibitor | 0.062 0.05 DBMET00688 | DBMET00688 | |
| 0.012 | 0.042 | 0.117 | AMPA 1 receptor antagonist | 0.117 0.005 DBMET00688 | DBMET00688 | |
| 0.082 | 0.113 | 0.095 | Folate antagonist | 0.095 0.074 DBMET00688 | DBMET00688 | |
| 0.109 | 0.14 | 0.144 | Hemostatic | 0.144 0.075 DBMET00688 | DBMET00688 | |
| 0.005 | 0.036 | 0.022 | Angiotensin AT1B receptor antagonist | 0.022 0.005 DBMET00688 | DBMET00688 | |
| 0.024 | 0.059 | 0.033 | Carboxypeptidase B inhibitor | 0.033 0.023 DBMET00688 | DBMET00688 | |
| 0.027 | 0.062 | 0.048 | Membrane dipeptidase inhibitor | 0.048 0.018 DBMET00688 | DBMET00688 | |
| 0.019 | 0.055 | 0.279 | Integrin antagonist | 0.279 0.005 DBMET00688 | DBMET00688 | |
| 0.037 | 0.073 | 0.051 | Bombesin 2 receptor antagonist | 0.051 0.032 DBMET00688 | DBMET00688 | |
| 0.032 | 0.068 | 0.038 | VCAM-1 antagonist | 0.038 0.031 DBMET00688 | DBMET00688 | |
| 0.081 | 0.117 | 0.099 | Alkylator | 0.099 0.089 DBMET00688 | DBMET00688 | |
| 0.028 | 0.064 | 0.068 | Glutamate (mGluR8) agonist | 0.068 0.005 DBMET00688 | DBMET00688 | |
| 0.054 | 0.09 | 0.108 | Glutamate (mGluR) antagonist | 0.108 0.031 DBMET00688 | DBMET00688 | |
| 0.032 | 0.068 | 0.038 | VCAM antagonist | 0.038 0.032 DBMET00688 | DBMET00688 | |
| 0.08 | 0.118 | 0.308 | Cholesterol synthesis inhibitor | 0.308 0.011 DBMET00688 | DBMET00688 | |
| 0.035 | 0.074 | 0.066 | GABA A receptor antagonist | 0.066 0.027 DBMET00688 | DBMET00688 | |
| 0.155 | 0.194 | 0.248 | DNA synthesis inhibitor | 0.248 0.068 DBMET00688 | DBMET00688 | |
| 0.047 | 0.088 | 0.072 | Carbonic anhydrase VA inhibitor | 0.072 0.044 DBMET00688 | DBMET00688 | |
| 0.123 | 0.165 | 0.158 | Ca2+-transporting ATPase inhibitor | 0.158 0.026 DBMET00688 | DBMET00688 | |
| 0.034 | 0.077 | 0.077 | GABA receptor antagonist | 0.077 0.023 DBMET00688 | DBMET00688 | |
| 0.057 | 0.102 | 0.169 | Keratolytic | 0.169 0.012 DBMET00688 | DBMET00688 | |
| 0.013 | 0.059 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 DBMET00688 | DBMET00688 | |
| 0.073 | 0.119 | 0.27 | Cystathionine beta-synthase inhibitor | 0.27 0.013 DBMET00688 | DBMET00688 | |
| 0.113 | 0.16 | 0.126 | CC chemokine 6 receptor antagonist | 0.126 0.086 DBMET00688 | DBMET00688 | |
| 0.035 | 0.083 | 0.042 | Heme oxygenase inhibitor | 0.042 0.031 DBMET00688 | DBMET00688 | |
| 0.047 | 0.094 | 0.069 | Caspase 9 inhibitor | 0.069 0.033 DBMET00688 | DBMET00688 | |
| 0.061 | 0.109 | 0.13 | GABA B receptor agonist | 0.13 0.005 DBMET00688 | DBMET00688 | |
| 0.03 | 0.079 | 0.067 | GABA B receptor antagonist | 0.067 0.009 DBMET00688 | DBMET00688 | |
| 0.027 | 0.075 | 0.054 | Thymidylate synthase inhibitor | 0.054 0.022 DBMET00688 | DBMET00688 | |
| 0.124 | 0.173 | 0.22 | Phospholipase C inhibitor | 0.22 0.034 DBMET00688 | DBMET00688 | |
| 0.047 | 0.097 | 0.2 | Glutamate decarboxylase inhibitor | 0.2 0.007 DBMET00688 | DBMET00688 | |
| 0.039 | 0.09 | 0.178 | Phosphofructokinase-1 inhibitor | 0.178 0.014 DBMET00688 | DBMET00688 | |
| 0.036 | 0.087 | 0.136 | Carbamoyl phosphate synthetase inhibitor | 0.136 0.013 DBMET00688 | DBMET00688 | |
| 0.096 | 0.147 | 0.144 | Cell wall synthesis inhibitor | 0.144 0.071 DBMET00688 | DBMET00688 | |
| 0.024 | 0.076 | 0.053 | Adenosine deaminase inhibitor | 0.053 0.027 DBMET00688 | DBMET00688 | |
| 0.024 | 0.077 | 0.063 | Sphingosine 1-phosphate receptor 1 agonist | 0.063 0.011 DBMET00688 | DBMET00688 | |
| 0.136 | 0.19 | 0.231 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.231 0.052 DBMET00688 | DBMET00688 | |
| 0.016 | 0.071 | 0.028 | Integrin alpha2beta1 antagonist | 0.028 0.014 DBMET00688 | DBMET00688 | |
| 0.008 | 0.063 | 0.017 | Nicotinic acid receptor 1 antagonist | 0.017 0.013 DBMET00688 | DBMET00688 | |
| 0.007 | 0.063 | 0.044 | Integrin beta3 antagonist | 0.044 0.007 DBMET00688 | DBMET00688 | |
| 0.026 | 0.082 | 0.077 | Ornithine carbamoyltransferase inhibitor | 0.077 0.023 DBMET00688 | DBMET00688 | |
| 0.026 | 0.082 | 0.07 | Sphingosine 1-phosphate receptor agonist | 0.07 0.011 DBMET00688 | DBMET00688 | |
| 0.024 | 0.081 | 0.04 | MAP3K5 inhibitor | 0.04 0.024 DBMET00688 | DBMET00688 | |
| 0.031 | 0.089 | 0.132 | Argininosuccinate synthase inhibitor | 0.132 0.014 DBMET00688 | DBMET00688 | |
| 0.117 | 0.175 | 0.141 | 3C-like protease (Human coronavirus) inhibitor | 0.141 0.117 DBMET00688 | DBMET00688 | |
| 0.176 | 0.235 | 0.51 | Toll-Like receptor 7 agonist | 0.51 0.03 DBMET00688 | DBMET00688 | |
| 0.034 | 0.092 | 0.168 | Biliverdin reductase inhibitor | 0.168 0.008 DBMET00688 | DBMET00688 | |
| 0.064 | 0.123 | 0.134 | NADH dehydrogenase inhibitor | 0.134 0.022 DBMET00688 | DBMET00688 | |
| 0.055 | 0.114 | 0.119 | NMDA receptor antagonist | 0.119 0.036 DBMET00688 | DBMET00688 | |
| 0.08 | 0.14 | 0.131 | Photosensitizer | 0.131 0.045 DBMET00688 | DBMET00688 | |
| 0.08 | 0.139 | 0.107 | TRPA1 agonist | 0.107 0.077 DBMET00688 | DBMET00688 | |
| 0.014 | 0.075 | 0.025 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.017 DBMET00688 | DBMET00688 | |
| 0.093 | 0.155 | 0.278 | Diuretic | 0.278 0.026 DBMET00688 | DBMET00688 | |
| 0.037 | 0.099 | 0.063 | Carbonic anhydrase V inhibitor | 0.063 0.05 DBMET00688 | DBMET00688 | |
| 0.176 | 0.239 | 0.211 | 15-Lipoxygenase inhibitor | 0.211 0.202 DBMET00688 | DBMET00688 | |
| 0.01 | 0.073 | 0.037 | Arginase inhibitor | 0.037 0.025 DBMET00688 | DBMET00688 | |
| 0.08 | 0.143 | 0.147 | Aldehyde dehydrogenase inhibitor | 0.147 0.049 DBMET00688 | DBMET00688 | |
| 0.051 | 0.114 | 0.069 | Exportin-1 inhibitor | 0.069 0.045 DBMET00688 | DBMET00688 | |
| 0.053 | 0.116 | 0.183 | Potassium channel (Ca-activated) activator | 0.183 0.018 DBMET00688 | DBMET00688 | |
| 0.174 | 0.237 | 0.508 | Toll-Like receptor agonist | 0.508 0.03 DBMET00688 | DBMET00688 | |
| 0.042 | 0.106 | 0.072 | Na+ K+ transporting ATPase inhibitor | 0.072 0.058 DBMET00688 | DBMET00688 | |
| 0.063 | 0.129 | 0.139 | UDP-glucose 4-epimerase inhibitor | 0.139 0.033 DBMET00688 | DBMET00688 | |
| 0.115 | 0.181 | 0.349 | Aldehyde oxidase inhibitor | 0.349 0.055 DBMET00688 | DBMET00688 | |
| 0.033 | 0.099 | 0.052 | Alpha-mannosidase inhibitor | 0.052 0.039 DBMET00688 | DBMET00688 | |
| 0.058 | 0.126 | 0.211 | HIV-1 integrase (Overall Integration) inhibitor | 0.211 0.009 DBMET00688 | DBMET00688 | |
| 0.023 | 0.092 | 0.056 | NMDA receptor subunit 3B antagonist | 0.056 0.021 DBMET00688 | DBMET00688 | |
| 0.011 | 0.08 | 0.036 | Lysophosphatidic acid 1 receptor antagonist | 0.036 0.005 DBMET00688 | DBMET00688 | |
| 0.029 | 0.098 | 0.089 | Glutamate (mGluR4) antagonist | 0.089 0.007 DBMET00688 | DBMET00688 | |
| 0.01 | 0.079 | 0.095 | AMPA 2 receptor antagonist | 0.095 0.005 DBMET00688 | DBMET00688 | |
| 0.075 | 0.147 | 0.192 | DOPA decarboxylase inhibitor | 0.192 0.008 DBMET00688 | DBMET00688 | |
| 0.12 | 0.194 | 0.266 | Interleukin agonist | 0.266 0.068 DBMET00688 | DBMET00688 | |
| 0.056 | 0.132 | 0.17 | Mediator release inhibitor | 0.17 0.021 DBMET00688 | DBMET00688 | |
| 0.021 | 0.097 | 0.039 | Integrin alpha2 antagonist | 0.039 0.022 DBMET00688 | DBMET00688 | |
| 0.16 | 0.235 | 0.399 | Antithrombotic | 0.399 0.049 DBMET00688 | DBMET00688 | |
| 0.076 | 0.153 | 0.172 | Cyclooxygenase 3 inhibitor | 0.172 0.032 DBMET00688 | DBMET00688 | |
| 0.011 | 0.092 | 0.052 | Liver X receptor beta antagonist | 0.052 0.008 DBMET00688 | DBMET00688 | |
| 0.022 | 0.103 | 0.041 | Mannosidase inhibitor | 0.041 0.038 DBMET00688 | DBMET00688 | |
| 0.027 | 0.108 | 0.066 | Kainate receptor agonist | 0.066 0.005 DBMET00688 | DBMET00688 | |
| 0.047 | 0.129 | 0.108 | Macrophage migration inhibitory factor inhibitor | 0.108 0.03 DBMET00688 | DBMET00688 | |
| 0.094 | 0.177 | 0.142 | Sphingosine 1-phosphate receptor 2 antagonist | 0.142 0.053 DBMET00688 | DBMET00688 | |
| 0.012 | 0.095 | 0.03 | Nicotinic acid receptor 2 antagonist | 0.03 0.013 DBMET00688 | DBMET00688 | |
| 0.014 | 0.098 | 0.065 | Retinoid X alpha receptor agonist | 0.065 0.01 DBMET00688 | DBMET00688 | |
| 0.019 | 0.103 | 0.041 | Phosphorylase inhibitor | 0.041 0.036 DBMET00688 | DBMET00688 | |
| 0.052 | 0.138 | 0.093 | MDM2 inhibitor | 0.093 0.009 DBMET00688 | DBMET00688 | |
| 0.07 | 0.156 | 0.161 | Bone formation stimulant | 0.161 0.051 DBMET00688 | DBMET00688 | |
| 0.015 | 0.102 | 0.048 | NMDA receptor subunit 3A antagonist | 0.048 0.021 DBMET00688 | DBMET00688 | |
| 0.011 | 0.098 | 0.06 | Kainate receptor 2 antagonist | 0.06 0.012 DBMET00688 | DBMET00688 | |
| 0.028 | 0.115 | 0.072 | Glutamate (mGluR) agonist | 0.072 0.035 DBMET00688 | DBMET00688 | |
| 0.029 | 0.118 | 0.09 | Leukotriene B4 antagonist | 0.09 0.013 DBMET00688 | DBMET00688 | |
| 0.028 | 0.118 | 0.075 | Glucose-6-phosphate isomerase inhibitor | 0.075 0.01 DBMET00688 | DBMET00688 | |
| 0.009 | 0.099 | 0.025 | Glutamate (mGluR1a) agonist | 0.025 0.012 DBMET00688 | DBMET00688 | |
| 0.112 | 0.203 | 0.265 | Succinate dehydrogenase inhibitor | 0.265 0.018 DBMET00688 | DBMET00688 | |
| 0.013 | 0.104 | 0.064 | Fumarate hydratase inhibitor | 0.064 0.009 DBMET00688 | DBMET00688 | |
| 0.041 | 0.133 | 0.079 | Leukotriene C antagonist | 0.079 0.008 DBMET00688 | DBMET00688 | |
| 0.022 | 0.113 | 0.07 | AMPA 4 receptor antagonist | 0.07 0.008 DBMET00688 | DBMET00688 | |
| 0.06 | 0.153 | 0.102 | Anabolic | 0.102 0.06 DBMET00688 | DBMET00688 | |
| 0.036 | 0.129 | 0.088 | Purinergic P2X1 antagonist | 0.088 0.021 DBMET00688 | DBMET00688 | |
| 0.024 | 0.118 | 0.063 | NMDA 2C receptor antagonist | 0.063 0.041 DBMET00688 | DBMET00688 | |
| 0.006 | 0.101 | 0.017 | Thromboxane A2 agonist | 0.017 0.009 DBMET00688 | DBMET00688 | |
| 0.019 | 0.115 | 0.1 | Thromboxane A2 antagonist | 0.1 0.008 DBMET00688 | DBMET00688 | |
| 0.009 | 0.105 | 0.067 | Prostacyclin antagonist | 0.067 0.008 DBMET00688 | DBMET00688 | |
| 0.051 | 0.149 | 0.158 | Cell adhesion molecule inhibitor | 0.158 0.014 DBMET00688 | DBMET00688 | |
| 0.022 | 0.121 | 0.112 | Thromboxane antagonist | 0.112 0.008 DBMET00688 | DBMET00688 | |
| 0.099 | 0.2 | 0.181 | Interferon gamma antagonist | 0.181 0.049 DBMET00688 | DBMET00688 | |
| 0.055 | 0.157 | 0.179 | Triose-phosphate isomerase inhibitor | 0.179 0.014 DBMET00688 | DBMET00688 | |
| 0.01 | 0.114 | 0.065 | Retinoid X receptor agonist | 0.065 0.012 DBMET00688 | DBMET00688 | |
| 0.011 | 0.117 | 0.08 | Free fatty acid receptor 1 antagonist | 0.08 0.004 DBMET00688 | DBMET00688 | |
| 0.029 | 0.135 | 0.121 | Leukotriene antagonist | 0.121 0.015 DBMET00688 | DBMET00688 | |
| 0.008 | 0.115 | 0.025 | Uridine phosphorylase inhibitor | 0.025 0.022 DBMET00688 | DBMET00688 | |
| 0.008 | 0.115 | 0.09 | Kynurenine 3 monooxygenase inhibitor | 0.09 0.004 DBMET00688 | DBMET00688 | |
| 0.026 | 0.134 | 0.054 | Leukotriene C4 antagonist | 0.054 0.008 DBMET00688 | DBMET00688 | |
| 0.027 | 0.135 | 0.073 | Glutamate (mGluR group III) antagonist | 0.073 0.009 DBMET00688 | DBMET00688 | |
| 0.034 | 0.145 | 0.058 | DNA gyrase inhibitor | 0.058 0.052 DBMET00688 | DBMET00688 | |
| 0.03 | 0.142 | 0.194 | Catalase inhibitor | 0.194 0.016 DBMET00688 | DBMET00688 | |
| 0.129 | 0.245 | 0.208 | 12-Lipoxygenase inhibitor | 0.208 0.143 DBMET00688 | DBMET00688 | |
| 0.023 | 0.14 | 0.086 | NMDA receptor glycine site agonist | 0.086 0.024 DBMET00688 | DBMET00688 | |
| 0.035 | 0.153 | 0.078 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.078 0.053 DBMET00688 | DBMET00688 | |
| 0.01 | 0.13 | 0.03 | Glutamate (mGluR2) antagonist | 0.03 0.019 DBMET00688 | DBMET00688 | |
| 0.082 | 0.206 | 0.178 | Mannose-6-phosphate isomerase inhibitor | 0.178 0.044 DBMET00688 | DBMET00688 | |
| 0.08 | 0.206 | 0.172 | Aryl hydrocarbon receptor agonist | 0.172 0.119 DBMET00688 | DBMET00688 | |
| 0.067 | 0.194 | 0.115 | Toll-Like receptor 2 antagonist | 0.115 0.084 DBMET00688 | DBMET00688 | |
| 0.06 | 0.188 | 0.122 | Caspase 3 inhibitor | 0.122 0.057 DBMET00688 | DBMET00688 | |
| 0.038 | 0.169 | 0.083 | GABA aminotransferase inhibitor | 0.083 0.043 DBMET00688 | DBMET00688 | |
| 0.006 | 0.139 | 0.096 | GP IIb/IIIa receptor antagonist | 0.096 0.018 DBMET00688 | DBMET00688 | |
| 0.051 | 0.185 | 0.193 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.193 0.017 DBMET00688 | DBMET00688 | |
| 0.057 | 0.191 | 0.082 | D-Ala-D-Ala ligase inhibitor | 0.082 0.063 DBMET00688 | DBMET00688 | |
| 0.056 | 0.191 | 0.153 | AMP-activated protein kinase stimulant | 0.153 0.027 DBMET00688 | DBMET00688 | |
| 0.015 | 0.151 | 0.063 | Glutamate (mGluR3) antagonist | 0.063 0.007 DBMET00688 | DBMET00688 | |
| 0.011 | 0.149 | 0.029 | Thyroid hormone agonist | 0.029 0.013 DBMET00688 | DBMET00688 | |
| 0.013 | 0.152 | 0.05 | Glutamate (mGluR group II) antagonist | 0.05 0.016 DBMET00688 | DBMET00688 | |
| 0.004 | 0.144 | 0.024 | Integrin alpha4beta7 antagonist | 0.024 0.012 DBMET00688 | DBMET00688 | |
| 0.013 | 0.153 | 0.05 | Guanylate cyclase inhibitor | 0.05 0.021 DBMET00688 | DBMET00688 | |
| 0.013 | 0.153 | 0.047 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.047 0.01 DBMET00688 | DBMET00688 | |
| 0.114 | 0.256 | 0.271 | Lipoxygenase inhibitor | 0.271 0.086 DBMET00688 | DBMET00688 | |
| 0.017 | 0.159 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.027 DBMET00688 | DBMET00688 | |
| 0.089 | 0.232 | 0.208 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.208 0.096 DBMET00688 | DBMET00688 | |
| 0.004 | 0.147 | 0.018 | Integrin beta7 antagonist | 0.018 0.015 DBMET00688 | DBMET00688 | |
| 0.152 | 0.296 | 0.248 | Antibacterial | 0.248 0.179 DBMET00688 | DBMET00688 | |
| 0.091 | 0.238 | 0.297 | Platelet aggregation inhibitor | 0.297 0.037 DBMET00688 | DBMET00688 | |
| 0.003 | 0.15 | 0.032 | G-protein-coupled receptor 120 agonist | 0.032 0.005 DBMET00688 | DBMET00688 | |
| 0.009 | 0.156 | 0.05 | Kainate receptor antagonist | 0.05 0.022 DBMET00688 | DBMET00688 | |
| 0.035 | 0.183 | 0.108 | Monophenol monooxygenase inhibitor | 0.108 0.07 DBMET00688 | DBMET00688 | |
| 0.005 | 0.155 | 0.028 | Prostaglandin EP2 agonist | 0.028 0.013 DBMET00688 | DBMET00688 | |
| 0.054 | 0.205 | 0.13 | Mucolytic | 0.13 0.046 DBMET00688 | DBMET00688 | |
| 0.073 | 0.228 | 0.137 | Sphingosine 1-phosphate receptor 4 antagonist | 0.137 0.046 DBMET00688 | DBMET00688 | |
| 0.007 | 0.165 | 0.033 | G protein-coupled receptor agonist | 0.033 0.032 DBMET00688 | DBMET00688 | |
| 0.071 | 0.231 | 0.196 | Phospholipase A2 inhibitor | 0.196 0.045 DBMET00688 | DBMET00688 | |
| 0.006 | 0.169 | 0.04 | Leukotriene B4 receptor 1 antagonist | 0.04 0.012 DBMET00688 | DBMET00688 | |
| 0.052 | 0.215 | 0.128 | ABCA1 expression enhancer | 0.128 0.025 DBMET00688 | DBMET00688 | |
| 0.006 | 0.172 | 0.037 | Leukotriene D4 antagonist | 0.037 0.013 DBMET00688 | DBMET00688 | |
| 0.065 | 0.232 | 0.134 | Anticoagulant | 0.134 0.095 DBMET00688 | DBMET00688 | |
| 0.039 | 0.207 | 0.097 | Peroxisome proliferator-activated receptor gamma antagonist | 0.097 0.017 DBMET00688 | DBMET00688 | |
| 0.04 | 0.21 | 0.089 | Sphingosine 1-phosphate receptor antagonist | 0.089 0.032 DBMET00688 | DBMET00688 | |
| 0.009 | 0.18 | 0.032 | Liver X receptor beta agonist | 0.032 0.024 DBMET00688 | DBMET00688 | |
| 0.132 | 0.304 | 0.374 | Sodium/bile acid cotransporter inhibitor | 0.374 0.026 DBMET00688 | DBMET00688 | |
| 0.008 | 0.182 | 0.021 | Retinoid X beta receptor antagonist | 0.021 0.014 DBMET00688 | DBMET00688 | |
| 0.073 | 0.246 | 0.146 | Hexokinase inhibitor | 0.146 0.084 DBMET00688 | DBMET00688 | |
| 0.066 | 0.241 | 0.3 | Pyruvate kinase inhibitor | 0.3 0.048 DBMET00688 | DBMET00688 | |
| 0.019 | 0.198 | 0.07 | Glucagon-like peptide 1 agonist | 0.07 0.041 DBMET00688 | DBMET00688 | |
| 0.008 | 0.19 | 0.041 | Carnitine palmitoyltransferase inhibitor | 0.041 0.015 DBMET00688 | DBMET00688 | |
| 0.038 | 0.222 | 0.087 | Glutamate (mGluR6) antagonist | 0.087 0.018 DBMET00688 | DBMET00688 | |
| 0.06 | 0.245 | 0.206 | Cell adhesion inhibitor | 0.206 0.023 DBMET00688 | DBMET00688 | |
| 0.08 | 0.265 | 0.2 | Immunostimulant | 0.2 0.12 DBMET00688 | DBMET00688 | |
| 0.003 | 0.19 | 0.018 | Kainate receptor 1 antagonist | 0.018 0.017 DBMET00688 | DBMET00688 | |
| 0.042 | 0.23 | 0.075 | Glutathione S-transferase inhibitor | 0.075 0.07 DBMET00688 | DBMET00688 | |
| 0.086 | 0.276 | 0.167 | Sphingosine 1-phosphate receptor 5 antagonist | 0.167 0.037 DBMET00688 | DBMET00688 | |
| 0.008 | 0.199 | 0.041 | Carnitine palmitoyltransferase 1 inhibitor | 0.041 0.015 DBMET00688 | DBMET00688 | |
| 0.009 | 0.2 | 0.036 | Nicotinic acid receptor agonist | 0.036 0.025 DBMET00688 | DBMET00688 | |
| 0.037 | 0.228 | 0.081 | Glycine receptor agonist | 0.081 0.037 DBMET00688 | DBMET00688 | |
| 0.005 | 0.196 | 0.018 | Thyroid hormone alpha antagonist | 0.018 0.009 DBMET00688 | DBMET00688 | |
| 0.027 | 0.223 | 0.048 | CD45 antagonist | 0.048 0.041 DBMET00688 | DBMET00688 | |
| 0.015 | 0.211 | 0.05 | Liver X receptor alpha agonist | 0.05 0.019 DBMET00688 | DBMET00688 | |
| 0.015 | 0.219 | 0.038 | Retinoid X alpha receptor antagonist | 0.038 0.017 DBMET00688 | DBMET00688 | |
| 0.026 | 0.23 | 0.065 | Cathepsin G inhibitor | 0.065 0.06 DBMET00688 | DBMET00688 | |
| 0.034 | 0.239 | 0.098 | Expectorant | 0.098 0.071 DBMET00688 | DBMET00688 | |
| 0.025 | 0.231 | 0.053 | Sphingosine 1-phosphate receptor 1 antagonist | 0.053 0.044 DBMET00688 | DBMET00688 | |
| 0.072 | 0.279 | 0.159 | DNA methylase inhibitor | 0.159 0.109 DBMET00688 | DBMET00688 | |
| 0.004 | 0.212 | 0.038 | VLA-4 antagonist | 0.038 0.015 DBMET00688 | DBMET00688 | |
| 0.069 | 0.278 | 0.272 | Interleukin antagonist | 0.272 0.054 DBMET00688 | DBMET00688 | |
| 0.023 | 0.233 | 0.058 | Heparanase inhibitor | 0.058 0.026 DBMET00688 | DBMET00688 | |
| 0.067 | 0.278 | 0.144 | DNA methyltransferase I inhibitor | 0.144 0.11 DBMET00688 | DBMET00688 | |
| 0.016 | 0.231 | 0.043 | Retinoid X receptor antagonist | 0.043 0.019 DBMET00688 | DBMET00688 | |
| 0.068 | 0.293 | 0.135 | Platelet adhesion inhibitor | 0.135 0.124 DBMET00688 | DBMET00688 | |
| 0.04 | 0.267 | 0.097 | Xanthine oxidase inhibitor | 0.097 0.063 DBMET00688 | DBMET00688 | |
| 0.046 | 0.273 | 0.095 | Interleukin 1b antagonist | 0.095 0.087 DBMET00688 | DBMET00688 | |
| 0.016 | 0.245 | 0.08 | Diacylglycerol O-acyltransferase inhibitor | 0.08 0.014 DBMET00688 | DBMET00688 | |
| 0.002 | 0.232 | 0.03 | Peroxisome proliferator-activated receptor alpha antagonist | 0.03 0.012 DBMET00688 | DBMET00688 | |
| 0.004 | 0.235 | 0.03 | Integrin alpha4 antagonist | 0.03 0.016 DBMET00688 | DBMET00688 | |
| 0.04 | 0.277 | 0.121 | Multidrug resistance-associated protein 1 inhibitor | 0.121 0.047 DBMET00688 | DBMET00688 | |
| 0.019 | 0.257 | 0.142 | Leukotriene synthesis inhibitor | 0.142 0.01 DBMET00688 | DBMET00688 | |
| 0.014 | 0.258 | 0.069 | Prostaglandin-E synthase inhibitor | 0.069 0.05 DBMET00688 | DBMET00688 | |
| 0.003 | 0.248 | 0.026 | Prostaglandin E2 agonist | 0.026 0.013 DBMET00688 | DBMET00688 | |
| 0.005 | 0.254 | 0.073 | Urate transporter 1 inhibitor | 0.073 0.009 DBMET00688 | DBMET00688 | |
| 0.007 | 0.26 | 0.064 | Peroxisome proliferator-activated receptor alpha agonist | 0.064 0.025 DBMET00688 | DBMET00688 | |
| 0.038 | 0.293 | 0.104 | Bile acid receptor antagonist | 0.104 0.041 DBMET00688 | DBMET00688 | |
| 0.008 | 0.266 | 0.032 | ATP citrate lysase inhibitor | 0.032 0.022 DBMET00688 | DBMET00688 | |
| 0.005 | 0.264 | 0.035 | Prostaglandin agonist | 0.035 0.017 DBMET00688 | DBMET00688 | |
| 0.062 | 0.334 | 0.157 | Hepatoprotectant | 0.157 0.102 DBMET00688 | DBMET00688 | |
| 0.04 | 0.325 | 0.108 | Nav1.4 sodium channel blocker | 0.108 0.065 DBMET00688 | DBMET00688 | |
| 0.076 | 0.365 | 0.166 | Lipocortins synthesis antagonist | 0.166 0.085 DBMET00688 | DBMET00688 | |
| 0.054 | 0.352 | 0.425 | Platelet antagonist | 0.425 0.023 DBMET00688 | DBMET00688 | |
| 0.004 | 0.304 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | 0.031 0.026 DBMET00688 | DBMET00688 | |
| 0.084 | 0.41 | 0.293 | Antiobesity | 0.293 0.121 DBMET00688 | DBMET00688 | |
| 0.007 | 0.344 | 0.047 | Prostaglandin E2 antagonist | 0.047 0.038 DBMET00688 | DBMET00688 | |
| 0.066 | 0.416 | 0.256 | Immunosuppressant | 0.256 0.143 DBMET00688 | DBMET00688 | |
| 0.019 | 0.382 | 0.077 | HIV-1 integrase inhibitor | 0.077 0.04 DBMET00688 | DBMET00688 | |
| 0.007 | 0.37 | 0.033 | Liver X receptor alpha antagonist | 0.033 0.014 DBMET00688 | DBMET00688 | |
| 0.031 | 0.406 | 0.111 | Amylase inhibitor | 0.111 0.088 DBMET00688 | DBMET00688 | |
| 0.006 | 0.386 | 0.088 | Prostaglandin EP2 antagonist | 0.088 0.023 DBMET00688 | DBMET00688 | |
| 0.023 | 0.406 | 0.084 | DNA helicase inhibitor | 0.084 0.009 DBMET00688 | DBMET00688 | |
| 0.023 | 0.41 | 0.092 | Potassium channel large-conductance Ca-activated activator | 0.092 0.028 DBMET00688 | DBMET00688 | |
| 0.006 | 0.395 | 0.414 | Prostaglandin antagonist | 0.414 0.004 DBMET00688 | DBMET00688 | |
| 0.006 | 0.395 | 0.03 | Liver X receptor antagonist | 0.03 0.022 DBMET00688 | DBMET00688 | |
| 0.014 | 0.41 | 0.144 | 5-Lipoxygenase inhibitor | 0.144 0.04 DBMET00688 | DBMET00688 | |
| 0.004 | 0.405 | 0.295 | Prostaglandin D2 antagonist | 0.295 0.004 DBMET00688 | DBMET00688 | |
| 0.004 | 0.416 | 0.028 | Retinoid X gamma receptor agonist | 0.028 0.012 DBMET00688 | DBMET00688 | |
| 0.039 | 0.462 | 0.17 | Interleukin 4 antagonist | 0.17 0.035 DBMET00688 | DBMET00688 | |
| 0.011 | 0.434 | 0.037 | Purinergic P2Y2 antagonist | 0.037 0.019 DBMET00688 | DBMET00688 | |
| 0.058 | 0.488 | 0.295 | Hypoglycemic | 0.295 0.054 DBMET00688 | DBMET00688 | |
| 0.009 | 0.439 | 0.065 | p53 inhibitor | 0.065 0.006 DBMET00688 | DBMET00688 | |
| 0.005 | 0.458 | 0.158 | Peroxisome proliferator-activated receptor gamma agonist | 0.158 0.011 DBMET00688 | DBMET00688 | |
| 0.045 | 0.502 | 0.128 | NOS3 expression enhancer | 0.128 0.1 DBMET00688 | DBMET00688 | |
| 0.029 | 0.5 | 0.109 | Interleukin 5 antagonist | 0.109 0.032 DBMET00688 | DBMET00688 | |
| 0.02 | 0.497 | 0.142 | Thrombolytic | 0.142 0.088 DBMET00688 | DBMET00688 | |
| 0.069 | 0.569 | 0.669 | Cyclophilin D inhibitor | 0.669 0.017 DBMET00688 | DBMET00688 | |
| 0.013 | 0.517 | 0.063 | Prostaglandin F2 alpha antagonist | 0.063 0.041 DBMET00688 | DBMET00688 | |
| 0.009 | 0.516 | 0.065 | Sphingosine 1-phosphate receptor 5 agonist | 0.065 0.02 DBMET00688 | DBMET00688 | |
| 0.003 | 0.544 | 0.022 | Retinoid X beta receptor agonist | 0.022 0.013 DBMET00688 | DBMET00688 | |
| 0.018 | 0.583 | 0.293 | Hypolipemic | 0.293 0.051 DBMET00688 | DBMET00688 | |
| 0.073 | 0.642 | 0.317 | Interleukin 2 agonist | 0.317 0.063 DBMET00688 | DBMET00688 | |
| 0.062 | 0.638 | 0.439 | Antiinflammatory | 0.439 0.116 DBMET00688 | DBMET00688 | |
| 0.011 | 0.598 | 0.18 | Cyclooxygenase 1 inhibitor | 0.18 0.043 DBMET00688 | DBMET00688 | |
| 0.004 | 0.615 | 0.051 | Carnitine palmitoyltransferase 1A inhibitor | 0.051 0.007 DBMET00688 | DBMET00688 | |
| 0.004 | 0.617 | 0.081 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.081 0.005 DBMET00688 | DBMET00688 | |
| 0.01 | 0.653 | 0.157 | Carnitine palmitoyltransferase 1B inhibitor | 0.157 0.004 DBMET00688 | DBMET00688 | |
| 0.004 | 0.669 | 0.036 | Peroxisome proliferator-activated receptor delta antagonist | 0.036 0.019 DBMET00688 | DBMET00688 | |
| 0.01 | 0.676 | 0.156 | Cyclooxygenase inhibitor | 0.156 0.065 DBMET00688 | DBMET00688 | |
| 0.002 | 0.719 | 0.027 | Free fatty acid receptor 1 agonist | 0.027 0.007 DBMET00688 | DBMET00688 | |
| 0.008 | 0.744 | 0.138 | Uric acid excretion stimulant | 0.138 0.028 DBMET00688 | DBMET00688 | |
| 0.004 | 0.783 | 0.31 | Aldose reductase inhibitor | 0.31 0.004 DBMET00688 | DBMET00688 | |
| 0.008 | 0.847 | 0.036 | Glutamate (mGluR8) antagonist | 0.036 0.023 DBMET00688 | DBMET00688 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |